High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma (Q77492326)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Nozomi Niitsu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Kimiko Iijima

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

241-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Expression and shedding of CD44 variant isoforms in patients with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Serological evaluation of soluble CD44 in renal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Individual Comparisons by Ranking Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

CD44: structure, function, and association with the malignant process.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Clinical significance of circulating CD44 in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900122-9

7 January 2021

10.1016/S0145-2126(01)00122-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792412%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference